High Sensitivity Mutation Screening and Clonal Analysis Allowed by Ultra-Deep Amplicon Sequencing Uncover the Complexity of Bcr-Abl Mutation Status in Patients Treated with Tyrosine Kinase Inhibitors / S Soverini; C De Benedittis; F Cattina; A Broucková; K Machová Poláková; D Russo; A Gnani; I Iacobucci; MT Bochicchio; F Castagnetti; G Gugliotta; F Palandri; C Papayannidis; H Klamová; A Vitale; M Vignetti; R Foà; G Rosti; M Baccarani; G Martinelli. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 97(s1):(2012), pp. 453-453. (Intervento presentato al convegno 17th Congress of the European Hematology Association tenutosi a Amsterdam, The Netherlands nel June 14 – 17, 2012).
High Sensitivity Mutation Screening and Clonal Analysis Allowed by Ultra-Deep Amplicon Sequencing Uncover the Complexity of Bcr-Abl Mutation Status in Patients Treated with Tyrosine Kinase Inhibitors
SOVERINI, SIMONA;DE BENEDITTIS, CATERINA;CATTINA, FEDERICA;IACOBUCCI, ILARIA;BOCHICCHIO, MARIA TERESA;CASTAGNETTI, FAUSTO;GUGLIOTTA, GABRIELE;PALANDRI, FRANCESCA;PAPAYANNIDIS, CRISTINA;ROSTI, GIANANTONIO;BACCARANI, MICHELE;MARTINELLI, GIOVANNI
2012
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
